GlaxoSmithKline Inc. Recalls

Overview of recall records associated with GlaxoSmithKline Inc., including dates, categories and classifications where available.

2recall records

Sep 5, 2012latest record date

Jul 18, 2012earliest record date

Recall history in this database

Classification mix: Class II: 2.

DrugSep 5, 2012

Ventolin HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 Metered recall — FDA D-1666-2012

Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.

Class IIFDA: TerminatedGlaxoSmithKline Inc.

DrugJul 18, 2012

GlaxoSmithKline Trizivir recall — FDA D-1412-2012

Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

Class IIFDA: TerminatedGlaxoSmithKline Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies GlaxoSmithKline Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.